|
DHX33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.522300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.692800E-01 |
| Normal-vs-Stage2 |
4.258000E-01 |
| Normal-vs-Stage3 |
2.837400E-01 |
| Normal-vs-Stage4 |
9.549800E-01 |
| Stage1-vs-Stage2 |
6.778000E-01 |
| Stage1-vs-Stage3 |
4.876800E-01 |
| Stage1-vs-Stage4 |
7.727200E-01 |
| Stage2-vs-Stage3 |
8.718200E-01 |
| Stage2-vs-Stage4 |
5.735800E-01 |
| Stage3-vs-Stage4 |
5.007800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.048200E-02 |
| Normal-vs-AfricanAmerican |
9.075600E-01 |
| Normal-vs-Asian |
9.395800E-01 |
| Caucasian-vs-AfricanAmerican |
1.878440E-01 |
| Caucasian-vs-Asian |
6.425400E-01 |
| AfricanAmerican-vs-Asian |
9.191600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.790000E-01 |
| Normal-vs-Female |
4.763300E-03 |
| Male-vs-Female |
1.502050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.737200E-01 |
| Normal-vs-Extreme_Weight |
7.016400E-01 |
| Normal-vs-Obese |
5.148000E-02 |
| Normal-vs-Extreme_Obese |
7.261600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.007800E-01 |
| Normal_Weight-vs-Obese |
1.160180E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.569800E-01 |
| Extreme_Weight-vs-Obese |
4.662400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.891200E-01 |
| Obese-vs-Extreme_Obese |
6.455600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.465900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.297640E-02 |
| Normal-vs-Age(61-80Yrs) |
7.152200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.206100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.127200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.245700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.579560E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.685900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.570200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.310580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.058400E-02 |
| Normal-VS-Type2 PRCC |
8.797800E-01 |
| Normal-VS-KIRP CIMP |
1.003210E-01 |
| Normal-VS-Unclassified PRCC |
6.042300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.639230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.812970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.846600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.644200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.135700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.620000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.141200E-01 |
| Normal-vs-N1 |
5.054000E-02 |
| Normal-vs-N2 |
1.937420E-01 |
| N0-vs-N1 |
3.343600E-02 |
| N0-vs-N2 |
7.110800E-01 |
| N1-vs-N2 |
2.254200E-01 |
|
|
